1. Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor
   Nobuyasu Takahashi et al, 2015, Human Cell CrossRef
2. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
   Yukihiro Haruyama, 2016, World Journal of Gastroenterology CrossRef
3. Establishment and characterization of an immortalized human hepatocyte line for the development of bioartificial liver system
   Qun Yan et al, 2018, Cytotechnology CrossRef
4. The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract—A Single-Center Retrospective Study
   Xiang-Xing Kong et al, 2021, Frontiers in Oncology CrossRef
5. Ampullary carcinoma—A genetic perspective
   Kaavya Jayaramayya et al, 2018, Mutation Research/Reviews in Mutation Research CrossRef
6. Pancreatic hepatoid carcinoma: A case report and literature review
   Yu-Ying Lei et al, 2021, World Academy of Sciences Journal CrossRef
7. Hepatoid carcinoma and related entities of the extrahepatic bile duct: A clinicopathological study of four cases
   Keisuke Okura et al, 2022, Pathology International CrossRef
8. Hepatoid Adenocarcinoma of the Extrahepatic Bile Duct in a Patient with Polysplenia Syndrome
   Kenji Yorita et al, 2017, Internal Medicine CrossRef
9. Enteroblastic adenocarcinoma of the ampulla of Vater
   Amanda Rodríguez-Villena et al, 2024, Revista Española de Patología CrossRef
10. Clinicopathological features and prognosis of intestinal hepatoid adenocarcinoma: evaluation of a pooled case series
    Xiangyu Zeng et al, 2018, Oncotarget CrossRef